Pre-Submission Review for Structural Biology Papers

Structural biology reviewers often ask:

• how was the sample prepared, purified, stabilized, and validated?

• do maps, density, restraints, or spectra support the model?

• are resolution, refinement, validation, and model statistics presented honestly?

• are PDB, EMDB, BMRB, SASBDB, or related depositions ready?

• does the wwPDB or database validation report support review?

• are flexible regions, ligands, interfaces, and conformational states interpreted cautiously?

• does functional or biochemical evidence support the structural claim?

• does the paper fit NSMB, Structure, Acta D, IUCrJ, Nature Communications, Molecular Cell, or a specialty venue?

The manuscript has to make the structure auditable.

In our pre-submission review work for structural biology manuscripts, we see a small set of specific failure patterns: the model is interesting, but the interpretation outruns the validation trail a reviewer can audit.

Density overread: flexible loops, ligands, side chains, interfaces, or conformational states are interpreted more strongly than the data support.

Validation gap: PDB or EMDB deposition, validation reports, map-model statistics, restraints, or raw-data access are not ready for review.

Mechanism leap: a structural difference is written as a functional mechanism without biochemical, mutational, kinetic, or cellular support.

Sample opacity: purification, construct design, complex assembly, ligand identity, buffer, crosslinking, or grid preparation is underreported.

Figure ambiguity: maps, models, interfaces, and comparison panels do not let reviewers see the evidence behind the claim.

A useful review should identify the first structural objection that would make a reviewer question the model or its interpretation.

Structural biology validation gap before journal review. In Manusights pre-submission review work, the highest-risk structural biology papers often have a plausible model but an incomplete validation trail. The abstract and Figure 1 may sell a mechanism, while the PDB or EMDB deposition, wwPDB validation report, local-resolution presentation, refinement statistics, restraints, or raw-map access still require extra interpretation from reviewers. We check whether the manuscript lets a reviewer move from coordinates, maps, validation reports, and methods to the stated claim without guessing.

Structural biology mechanism leap from shape to function. The second pattern is treating a structural difference as a biological mechanism before the functional evidence supports it. Cryo-EM, crystallography, NMR, SAXS, and integrative modeling papers can all fall into this trap: the Discussion says the interface explains activity, but the controls, mutational test, kinetic assay, binding experiment, or cellular phenotype is missing or underpowered. We mark the exact figure, method, control, or supplementary panel where the structure-function bridge breaks.

Structural biology journal-fit mismatch. The third pattern is a manuscript written for the wrong structural venue. Some papers belong at NSMB, Structure, Acta D, IUCrJ, Nature Communications, Molecular Cell, or a specialist protein venue, but the title and cover letter do not match the actual contribution. A validation-heavy method paper, a resource structure, and a mechanism paper need different first figures, comparison panels, source data, and journal targets. A useful review names the realistic route before submission.

Check whether your structural biology package is review-ready ->

Nature Structural & Molecular Biology requires data availability statements and points authors reporting macromolecular structures toward wwPDB and EMDB. wwPDB journal guidance says authors should submit the full validation report for manuscript review at submission. IUCr guidance states that structural papers are required to presubmit data to the PDB and provide deposition codes and validation reports.

Those policies matter because structural biology review is evidence-audit heavy. The database package is not a final production step. It is part of peer review.

Send the manuscript, target journal, structure files, validation reports, PDB or EMDB accession plan, map or density files if available, processing workflow, refinement statistics, construct and sample-prep details, ligand and complex information, biochemical or functional validation, figure panels, supplement, and prior reviewer comments.

For cryo-EM papers, include map resolution, local resolution, processing workflow, particle selection, model-building details, and representative density. For crystallography, include data collection, refinement, R factors, geometry, electron density, and PDB validation. For NMR or SAXS, include restraints, ensemble logic, and model uncertainty.

A useful structural biology pre-submission review should include:

• structure-function claim verdict

• sample and data-quality critique

• map-model or density-interpretation review

• validation and deposition readiness note

• functional-support and mechanism check

• figure and supplement review

• journal-lane recommendation

• submit, revise, retarget, or diagnose deeper call

The review should not only say "improve validation." It should identify which structural claim is not yet earned.

Before submission, authors often need to:

• prepare PDB, EMDB, BMRB, or SASBDB accessions and validation reports

• tone down claims about weak density or flexible regions

• add representative map or density panels

• clarify sample-preparation and complex-assembly details

• add biochemical or mutational validation

• separate AlphaFold-guided hypotheses from experimentally determined structure

• improve figure labeling, interface views, and comparison panels

• retarget from NSMB or broad biology to Structure, Acta D, IUCrJ, Protein Science, or a specialist venue

These fixes make the structure easier to trust.

A cryo-EM paper needs map quality, local-resolution honesty, processing transparency, and model validation. A crystallography paper needs deposition, refinement, geometry, and density support. An NMR paper needs restraints, ensemble interpretation, and uncertainty. A SAXS paper needs model ambiguity and concentration behavior handled carefully. An integrative modeling paper needs evidence weights and restraint transparency. A structure-function paper needs functional validation that turns the structure into biology.

The AI manuscript review can flag whether the blocking risk is validation, deposition, density interpretation, functional evidence, or journal fit.

Use this page when the manuscript's submission risk depends on structure quality, map-model agreement, density interpretation, structural validation, coordinates, structural deposition, or structure-function fit. Use molecular biology review when perturbation, pathway logic, reagents, cell models, and causal mechanism are the main submission risks.

That distinction keeps the page focused on the structural biology buyer's actual problem.

Do not submit a structural biology paper if deposition and validation reports are not ready. Reviewers may need those materials to judge the model, and late preparation often exposes problems that should be fixed before submission.

Also pause if the manuscript overreads weak density. It is better to be precise about uncertainty than to make a claim reviewers can disprove by looking at the map.

For structure-function papers, pause if function is inferred only from shape. Structural difference is not automatically mechanism.

For AlphaFold-assisted work, pause if predicted and experimental evidence are blurred. Reviewers need to know what was measured, what was modeled, and what was inferred.

For ligand-bound structures, pause if occupancy, chemistry, and surrounding density are not shown clearly.

Ready to submit if:

• model and map evidence are auditable

• validation reports and depositions are ready

• figures show the structural evidence clearly

• function claims have support beyond shape

• uncertainty is handled honestly

• target journal matches the structure's importance

Pause first if:

• accessions or reports are not ready

• weak density carries the main claim

• functional evidence is thin

• predicted and measured structures are blurred